February 12th 2025
Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, looks at what is involved in developing modern ADCs.
September 13th 2024
Willow Biosciences Announces Collaboration with Biopharma Company
August 22nd 2023The collaboration partner for Willow is focused on more sustainable methods to manufacture intermediates and APIs at reduced cost and less waste, in addition to looking for Willow’s expertise in developing and scaling key ingredients.
Piramal Pharma Solutions Expands and Upgrades UK Manufacturing Facilities
February 11th 2022Piramal Pharma Solutions plans to construct a multipurpose ADC manufacturing and aseptic fill/finish facility in Grangemouth, Scotland, and to upgrades its existing API manufacturing facility in Morpeth, England.
Lonza and Moderna to Expand Their COVID-19 Vaccine Drug Substance Manufacturing Collaboration
June 2nd 2021The companies are expanding their collaboration to extend the drug substance manufacturing of Moderna’s COVID-19 vaccine with the addition of a new manufacturing line at Lonza’s Geleen, Netherlands, site.